Wealth Effects LLC
- SEC CIK
- 0001907254
- Latest filing
- Aug 6, 2026
AKBA holding history
Akebia Therapeutics, Inc. in every 13F filed by Wealth Effects LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AKBA overviewAll 13F holders of AKBAFull Q2 2026 holdings
- Shares (Q2 2026)
- 12,000
- Value
- $13.7K
- % of portfolio
- <0.1%
- Quarters held
- 18
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 12,000 | $13.7K | <0.1% | −4,000−25.0% | Reduced | Holders |
| Q1 2026 | 16,000 | $22.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 16,000 | $25.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 16,000 | $43.7K | <0.1% | −18,500−53.6% | Reduced | Holders |
| Q2 2025 | 34,500 | $125.6K | <0.1% | +2,500+7.8% | Added | Holders |
| Q1 2025 | 32,000 | $61.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 32,000 | $60.8K | <0.1% | +5,000+18.5% | Added | Holders |
| Q3 2024 | 27,000 | $35.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 27,000 | $27.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 27,000 | $49.4K | <0.1% | −2,500−8.5% | Reduced | Holders |
| Q4 2023 | 29,500 | $36.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 29,500 | $33.6K | <0.1% | +11,184+61.1% | Added | Holders |
| Q2 2023 | 18,316 | $16.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 18,316 | $10.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 18,316 | $10.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 18,316 | $6.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 18,316 | $6.00K | <0.1% | −512−2.7% | Reduced | Holders |
| Q1 2022 | 18,828 | $14.0K | <0.1% | +18,828 | New | Holders |